Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • Latest News
    • A step towards new...

    A step towards new drug for life-threatening Cryptococcus neoformans infections

    Written by Ruby khatun khatun Published On 2017-10-17T19:00:37+05:30  |  Updated On 17 Oct 2017 7:00 PM IST
    A step towards new drug for life-threatening Cryptococcus neoformans infections

    A team from Sydney's Westmead Institute for Medical Research is a step closer to developing a drug to treat life-threatening fungal infections that cause more than 1.6 million deaths annually.




    Death rates due to fungal infections are similar to those of tuberculosis and greater than those due to malaria.


    The team discovered that Arg1, a protein produced by all fungi, enables the Cryptococcus neoformans fungus to establish potentially lethal infections in patients with weakened immune systems, such as those with HIV/AIDS or leukemia.


    Lead researcher, Associate Professor Julianne Djordjevic, said she is optimistic this discovery will provide a new avenue for the development of safer urgently needed antifungal drugs.


    "Finding new treatments to kill fungi is a major health priority. Novel antifungal drugs are desperately needed to reduce the high global morbidity, mortality and cost associated with treating invasive fungal infections.


    "Because fungi are so similar to human cells, developing new drugs that kill fungi -- but are non-toxic to humans -- is a challenge. Furthermore not all antifungal drugs kill all types of fungi and drug-resistance is an emerging problem.


    "By investigating how fungi cause disease, we have identified a new drug target with the view to design new therapies to combat these serious infections," she said.


    Cryptococcus neoformans is the world's most common cause of fungal meningitis.


    The primary site of infection is the lung. After inhalation from the environment, the infection spreads from the lung to the brain via the bloodstream.


    Immunosuppressed patients typically present with meningitis, which is fatal without treatment.


    Associate Professor Djordjevic and her team identified the Arg1 protein as part of their investigation of the mechanisms that fungi exploit to cause life-threatening infections in the body.


    "Our laboratory has established reliable methods for studying Cryptococcus neoformans at the molecular level.


    "Using gene deletion analysis and animal infection models, we identified that the Arg1 metabolic pathway allows Cryptococcus to establish a lung infection and to spread to brain, resulting in meningitis.


    "We are now looking at Arg1 as a selective target for antifungal drug development. By targeting Arg1, we hope to block the Arg1 metabolic pathway and thereby prevent Cryptococcus from establishing a lung infection and spreading to the brain," Associate Professor Djordjevic explained.


    Associate Professor Djordjevic said that even with appropriate treatment, high mortalities are reported highlighting the need to develop more effective antifungal therapies.


    "Fungal diseases are a growing global health problem and a leading cause of blindness, respiratory disease, meningitis and death.


    "Treatments with fewer side effects will significantly increase the chances of recovery for a patient, potentially saving thousands of lives every year," Associate Professor Djordjevic concluded.



    Cryptococcusfungal infectionsJulianne Djordjevicmeningitisrespiratory diseaseWestmead Institute for Medical Research

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby khatun khatun
    Ruby khatun khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok